PhysioAssist
Medical device intended for patients with obstructive pathologies .
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | €0.0 | round |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
* | $32.0m Valuation: $32.0m | Acquisition | |
| Total Funding | 000k | ||
| EUR | 2016 | 2017 |
|---|---|---|
| Revenues | 0000 | 0000 |
| % growth | - | 81 % |
| EBITDA | 0000 | 0000 |
| % EBITDA margin | (571 %) | (1278 %) |
| Profit | 0000 | 0000 |
| % profit margin | (840 %) | (1887 %) |
| EV | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 |
Source: Company filings or news article
Related Content
PhysioAssist is a healthcare company specializing in innovative solutions for chronic respiratory conditions. The company operates in the medical device market, focusing on products that aid in airway clearance for patients suffering from diseases such as cystic fibrosis, bronchiectasis, and chronic obstructive pulmonary disease (COPD). Their flagship product, Simeox, is designed to provide an efficient and fatigue-free approach to bronchial decongestion, improving the quality of life for patients and easing the burden on healthcare professionals.
PhysioAssist primarily serves healthcare professionals and their patients, offering both the Simeox device and an online training program through the Simeox Academy. This program provides essential knowledge in physiology, physiopathology, and respiratory physiotherapy, ensuring that healthcare providers can effectively utilize the Simeox device in clinical practice.
The company generates revenue through the sale of its medical devices and related training programs. By focusing on innovation and the specific needs of chronic respiratory patients, PhysioAssist positions itself as a leader in respiratory management solutions.
Keywords: airway clearance, chronic respiratory, cystic fibrosis, bronchiectasis, COPD, medical device, Simeox, bronchial decongestion, healthcare professionals, respiratory management.